Llwytho...
The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma
OBJECTIVE: Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma (EBV(‐pos) DLBCL) is a recently identified entity. Data regarding outcome to frontline immuno‐chemotherapy are conflicting. Although the prognostic impact of the tumour microenvironment (TME) in EBV(‐neg) DLBCL is well‐established,...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Eur J Haematol |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899834/ https://ncbi.nlm.nih.gov/pubmed/31211907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejh.13274 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|